Kintara Therapeutics
Why Robinhood?
You can watch KTRA and buy or sell other stocks, ETFs, and their options commission-free!About KTRA
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
KTRA Key Statistics
Stock Snapshot
With a market cap of 5.4M, Kintara Therapeutics(KTRA) trades at $0.12. The stock has a price-to-earnings ratio of -0.34.
On 2026-05-15, Kintara Therapeutics(KTRA) stock opened at —, reached a high of —, and a low of —.
The Kintara Therapeutics(KTRA)'s current trading volume is 0, compared to an average daily volume of 98.35K.
In the last year, Kintara Therapeutics(KTRA) shares hit a 52-week high of $7.93 and a 52-week low of $1.80.
In the last year, Kintara Therapeutics(KTRA) shares hit a 52-week high of $7.93 and a 52-week low of $1.80.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.